BR9301273A - Composto,formulacao farmaceutica,processo para preparar um composto e composto obtido - Google Patents

Composto,formulacao farmaceutica,processo para preparar um composto e composto obtido

Info

Publication number
BR9301273A
BR9301273A BR9301273A BR9301273A BR9301273A BR 9301273 A BR9301273 A BR 9301273A BR 9301273 A BR9301273 A BR 9301273A BR 9301273 A BR9301273 A BR 9301273A BR 9301273 A BR9301273 A BR 9301273A
Authority
BR
Brazil
Prior art keywords
compound
prepare
pharmaceutical formulation
compound obtained
formulation
Prior art date
Application number
BR9301273A
Other languages
English (en)
Inventor
Lynn Stacy Gossett
Chuah Shih
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9301273A publication Critical patent/BR9301273A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR9301273A 1992-03-24 1993-03-23 Composto,formulacao farmaceutica,processo para preparar um composto e composto obtido BR9301273A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/856,611 US5196424A (en) 1992-03-24 1992-03-24 N-[2-amino-4-substituted[[(pyrrollo or pyrido)[2,3-d]pyrimidinyl]-alkyl]benzoyl]-L-glutamic acids

Publications (1)

Publication Number Publication Date
BR9301273A true BR9301273A (pt) 1993-09-28

Family

ID=25324069

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9301273A BR9301273A (pt) 1992-03-24 1993-03-23 Composto,formulacao farmaceutica,processo para preparar um composto e composto obtido

Country Status (18)

Country Link
US (1) US5196424A (pt)
EP (1) EP0567223A1 (pt)
JP (1) JPH0625246A (pt)
KR (1) KR930019676A (pt)
CN (1) CN1078235A (pt)
AU (1) AU3542993A (pt)
BR (1) BR9301273A (pt)
CA (1) CA2091978A1 (pt)
CZ (1) CZ44093A3 (pt)
FI (1) FI931251A (pt)
HU (1) HUT70036A (pt)
IL (1) IL105100A0 (pt)
MX (1) MX9301544A (pt)
MY (1) MY131322A (pt)
NO (1) NO931008L (pt)
NZ (1) NZ247193A (pt)
TW (1) TW224098B (pt)
ZA (1) ZA931944B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457056A (en) * 1993-07-06 1995-10-10 Fiberchem, Inc. Halohydrocarbon sensing chemistry with base modifier
US6537999B2 (en) * 1996-06-06 2003-03-25 Duquesne University Of The Holy Ghost Pyrimidine derivatives and methods of making and using these derivatives
AU4163197A (en) * 1996-08-30 1998-03-19 Eli Lilly And Company Nonclassical pyrrolo{2,3-d}pyrimidine antifolates
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
US8030319B2 (en) * 2005-02-10 2011-10-04 Duquesne University Of The Holy Ghost Methods for treating cancer and other pathological proliferating disorders by inhibiting mitosis using pyrrolo[2 3-d]pyrimidines
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
CN1962658B (zh) * 2005-11-10 2010-05-12 北京大学 一种四氢吡啶并[3,2-d]嘧啶类化合物及制备抗肿瘤药物的用途
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
WO2010095940A2 (en) 2009-02-20 2010-08-26 To-Bbb Holding B.V. Glutathione-based drug delivery system
KR101741629B1 (ko) 2009-05-06 2017-05-31 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
KR20120103604A (ko) * 2009-11-06 2012-09-19 첼시 쎄라퓨틱스, 인코포레이티드 효소 저해성 화합물
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN102977107B (zh) * 2012-12-25 2015-04-22 山西普德药业股份有限公司 一种培美曲塞二钠化合物及其组合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59170091A (ja) * 1983-03-17 1984-09-26 Takeda Chem Ind Ltd ６−チオ−７−デアザプリン誘導体およびその製造法
DE3472258D1 (de) * 1983-03-17 1988-07-28 Takeda Chemical Industries Ltd Thiodeazapurine derivatives
AU559561B2 (en) * 1983-12-27 1987-03-12 Sri International 8,10-dideazaminopterins
US4927828A (en) * 1985-03-08 1990-05-22 The Trustees Of Princeton University Diastereoisomeric tetrahydropyrido-(2,3,d) pyrimidine derivatives
ZA861235B (en) * 1985-03-08 1986-10-29 Univ Princeton Pyrido(2,3-d)pyrimidine derivatives
US5026851A (en) * 1985-03-08 1991-06-25 The Trustees Of Princeton University Pyrido[2,3-]pyrimidine derivatives
US4684653A (en) * 1985-03-08 1987-08-04 The Trustees Of Princeton University Pyrido(2,3-d)pyrimidine derivatives
US4923872A (en) * 1986-08-26 1990-05-08 Warner-Lambert Co. Analogues of pyrrolo[3,2d]pyrimidin-4-ones
US4988702A (en) * 1986-08-26 1991-01-29 Warner-Lambert Company Novel 9-deazaguanines
US4988813A (en) * 1986-10-20 1991-01-29 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
US4902796A (en) * 1986-10-20 1990-02-20 The Trustees Of Princeton University 6-alkenyl and ethynyl derivatives of 2-amino-4-hydroxypyrido[2,3-d]pyrimidines
US4921858A (en) * 1986-10-24 1990-05-01 Warner-Lambert Company 7-deazaguanines as immunomodulators
JP2830008B2 (ja) * 1988-04-01 1998-12-02 武田薬品工業株式会社 縮合ピリミジン誘導体
NO169490C (no) * 1988-03-24 1992-07-01 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater
US4882333A (en) * 1988-05-25 1989-11-21 The Trustess Of Princeton University N-(5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-yl-alkanoyl)-glutamic acid derivatives
CH677140A5 (pt) * 1988-10-11 1991-04-15 W & E Umwelttechnik Ag
WO1991004254A1 (fr) * 1989-09-19 1991-04-04 Teijin Limited DERIVE DE PYRROLO[2,3-d]PYRIMIDINE, SON PROCEDE DE PREPARATION, ET PREPARATION PHARMACEUTIQUE COMPRENANT LE DERIVE COMME INGREDIENT ACTIF
CA2032695A1 (en) * 1989-12-20 1991-06-21 Hiroshi Akimoto Condensed heterocyclic compounds, their production and use

Also Published As

Publication number Publication date
CN1078235A (zh) 1993-11-10
JPH0625246A (ja) 1994-02-01
NO931008L (no) 1993-09-27
MY131322A (en) 2007-08-30
NZ247193A (en) 1995-05-26
NO931008D0 (no) 1993-03-19
ZA931944B (en) 1994-09-18
IL105100A0 (en) 1993-12-28
TW224098B (pt) 1994-05-21
FI931251A (fi) 1993-09-25
CA2091978A1 (en) 1993-09-25
US5196424A (en) 1993-03-23
AU3542993A (en) 1993-09-30
EP0567223A1 (en) 1993-10-27
FI931251A0 (fi) 1993-03-22
HU9300804D0 (en) 1993-06-28
HUT70036A (en) 1995-09-28
CZ44093A3 (en) 1994-02-16
KR930019676A (ko) 1993-10-18
MX9301544A (es) 1994-07-29

Similar Documents

Publication Publication Date Title
BR9202522A (pt) Composto,formulacao farmaceutica e processo para preparar um composto
BR1100850A (pt) Composto, processo para a preparação de um composto, e, composição farmacêutica
BR9301342A (pt) Composto,formulacao e composicao farmaceutica,processo para preparar um composto
BR9301137A (pt) Composto,formulacao farmaceutica,sulfonamida e processo para sua preparacao
BR1100323A (pt) Composto, uso de um composto, composição farmacêutica e processo para preparar um composto
BR9204361A (pt) Composto e processo para sua preparacao formulacao farmaceutica e intermediario
BR9501770A (pt) Uso de um composto,composto,formulação farmacêutica e processo para preparar um composto
BR9000040A (pt) Derivados de 3-aril-pirrolidin-2,4-diona,processo para sua preparacao,composicoes inseticidas,processos para combater insetos e para a preparacao de composicoes e aplicacao
BR9503638A (pt) Composto processo para sua produção e formulação farmacêutica
BR9504509A (pt) Composto processo para sua preparaçao e formulaçao farmaceûtica
BR9600821A (pt) Composto formulação farmacêutica e processo para a preparação de um composto
BR9404809A (pt) Composto, uso, formulação farmacêutica e processo para preparar um composto
BR9200951A (pt) Compostos, processo para sua producao,preparacoes farmaceuticas e uso
BR9605354A (pt) Composto composição farmacêutica processo para a produção do composto e uso
BR9103036A (pt) Composto,formulacao farmaceutica e processo para a preparacao do composto
BR9101121A (pt) Composto,processo para sua preparacao,suas aplicacoes,e preparado farmaceutico
BR9202325A (pt) Composto,processo para a sua preparacao,preparado farmaceutico e processo para a sua preparacao
BR9301273A (pt) Composto,formulacao farmaceutica,processo para preparar um composto e composto obtido
BR9302389A (pt) Composto,formulacao farmaceutica e processo para preparar o composto
BR9305161A (pt) Composto, composição farmacêutica e processo para a preparação do composto
BR8904212A (pt) Processo para preparar 1,3,5-trinitro-2,4,6-tripicrilbenzeno e composto
BR9002805A (pt) Derivados de 2-acilamino-4-halogeno-5-nitrotiazol,processo para a sua preparacao,sua aplicacao,composicao praguicida,processo para sua preparacao,processo para combater pragas,derivados de 4-halogeno-2-halogenocarbonilamino-5-nitrotiazol,processo para sua preparacao e sua aplicacao
BR9300034A (pt) Composto,processo para sua producao e composicao curavel
BR9406924A (pt) Composto processo para preparar o mesmo formulaçao farmaceutica e uso de um composto
BR9205020A (pt) Composto,formulacao farmaceutica,processo para preparar uma sulfonimidamida e sulfonimidamida obtida

Legal Events

Date Code Title Description
EE Request for examination
HHEE Republication of request for examination (correction)
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal